Before the Bell
$
63.29
Change
-0.57 -0.89%
Volume
Volume 41,057
Aug 8, 2016, 8:40 a.m.
Real time quotes
Previous close
$ 63.86
$ 63.86
Change
+6.02 +10.41%
Day low
Day high
$60.74
$64.00
52 week low
52 week high
$45.69
$64.00
Market cap
$176.77B
Average volume
10.13M
P/E ratio
35.09
Rev. per Employee
$575,456
EPS
1.82
Dividend
0.46
Div yield
2.88%
Ex dividend date
9/13/16
MarketWatch News on MRK
-
Merck stock price target raised to $63 from $58 at Leerink Partners
- Tomi Kilgore
-
Rise of Merck shares contributes nearly 30 points to Dow's early gain after rival's drug trial fails
- Mark DeCambre
-
Shares of Merck soar 6.4% in early trade to $61.43
- Mark DeCambre
-
Merck's stock on track to open at highest level since December 2001
- Tomi Kilgore
-
Merck's stock soars 11% in premarket trade
- Tomi Kilgore
-
Biogen's stock resumes trade, soars 7.9% after WSJ report of buyout interest from Merck, Allergan
- Tomi Kilgore
-
Biogen draws buyout interest from Merck, Allergan--WSJ
- Tomi Kilgore
-
S&P 500 ends just shy of record; Dow limps lower
- Sara Sjolin
-
Shares of Merck rise 0.7% in early trade to $58.87 to lead Dow gainers
- Mark DeCambre
-
These sorry stocks are soaring — and that’s a red flag for this rally
- Victor Reklaitis
-
Merck revenue boosted by cancer, hepatitis drugs
- MarketWatch.com
-
Merck's stock jumps 1.9% premarket after Q2 results
- Tomi Kilgore
-
Merck's profit and revenue rise above expectations
- Tomi Kilgore
-
Merck Q2 Januvia/Janumet revenue up 2% at $1.63 bln; FactSet consensus $1.61 bln
- Tomi Kilgore
-
Merck sees 2016 adj. EPS $3.67-$3.77; FactSet consensus $3.72
- Tomi Kilgore
- Loading more headlines...
Where does this data come from?
Analyst Estimates »
A data point based on hundreds of brokers buy, sell and hold rating.
Sentiment on MRK
Analyst Ratings
Other News on MRK
-
Top 10 Consumer Staples: Are There Any Worthy Buys? Part 4
- Seeking Alpha
-
Bristol-Myers Squibb: Buy It Even Cheaper
- Seeking Alpha
-
BMO Capital Upgrades Merck To Outperform, Bullish On Co
- benzinga.com
-
Takeaways, Observations and Tesla: Best of Kass
- TheStreet.com
-
U.S. Market Indexes Higher After Positive Jobs Report
- GuruFocus.com
-
Bristol-Myers Shares Sink as Lung-Cancer Drug Misses Goal
- The Wall Street Journal Interactive Edition
-
Stocks Surge on Strong Employment Report
- The Wall Street Journal Interactive Edition
-
Top Stock Holdings Of Hottest Growth Mutual Funds Since Brexit
- Investors Business Daily
-
Merck Dominates DJIA Boost Friday
- 247WallSt.com
-
S&P 500 Positive for Week After July Jobs Surge
- TheStreet.com
-
Bristol-Myers Plunges On Surprise Opdivo Failure In Lung Cancer
- Investors Business Daily
-
Jobs Boom Lifts Stocks; Tesla Leads Tech M&A; Auto Sales Stall In Busy Week
- Investors Business Daily
- Loading more headlines...
Press Releases on MRK
-
Diabetes World Drug Market Report 2016-2026
- PR Newswire - PRF
-
Medical Affiars Reputation: Multiple Sclerosis (US)
- PR Newswire - PRF
-
Nanoco and Merck Sign Agreement to Market Cadmium-free Quantum Dots
- BusinessWire - BZX
-
Mylan Launches Generic Propecia® Tablets
- PR Newswire - PRF
-
Agar Market: Global Industry Analysis and Opportunity Assessment, 2016 - 2026
- PR Newswire - PRF
-
Avitide, Inc., to Expand Affinity Separation Discovery and Manufacturing Operations
- BusinessWire - BZX
-
Merck Announces Fourth-Quarter 2016 Dividend
- BusinessWire - BZX
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com
| Avg. APR | Last Week | 6 Months | |
|---|---|---|---|
| Low Interest | 11.98% | 11.98% | 11.96% |
| Business | 13.12% | 13.12% | 13.12% |
| Student | 13.42% | 13.42% | 13.42% |
| Balance Transfer | 14.38% | 14.38% | 14.35% |
| Airline | 15.08% | 15.08% | 15.17% |
| Reward | 15.29% | 15.29% | 15.28% |
| Cash Back | 15.32% | 15.32% | 15.26% |
| Instant Approval | 18.04% | 18.04% | 18.21% |
| Bad Credit | 22.56% | 22.56% | 22.88% |




